目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?

8 Company Profiles
8.1. AstraZeneca PLC
8.2. Novartis AG
8.3. GE Healthcare
8.4. GSK plc.

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: United Kingdom biotechnology industry value: $ billion, 2016-21
Table 2: United Kingdom biotechnology industry category segmentation: % share, by value, 2016-2021
Table 3: United Kingdom biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: United Kingdom biotechnology industry geography segmentation: $ billion, 2021
Table 5: United Kingdom biotechnology industry value forecast: $ billion, 2021-26
Table 6: AstraZeneca PLC: key facts
Table 7: AstraZeneca PLC: Annual Financial Ratios
Table 8: AstraZeneca PLC: Key Employees
Table 9: Novartis AG: key facts
Table 10: Novartis AG: Annual Financial Ratios
Table 11: Novartis AG: Key Employees
Table 12: Novartis AG: Key Employees Continued
Table 13: GE Healthcare: key facts
Table 14: GE Healthcare: Key Employees
Table 15: GE Healthcare: Key Employees Continued
Table 16: GSK plc.: key facts
Table 17: GSK plc.: Annual Financial Ratios
Table 18: GSK plc.: Key Employees
Table 19: GSK plc.: Key Employees Continued
Table 20: United Kingdom size of population (million), 2017-21
Table 21: United Kingdom gdp (constant 2005 prices, $ billion), 2017-21
Table 22: United Kingdom gdp (current prices, $ billion), 2017-21
Table 23: United Kingdom inflation, 2017-21
Table 24: United Kingdom consumer price index (absolute), 2017-21
Table 25: United Kingdom exchange rate, 2017-21

List of Figures
Figure 1: United Kingdom biotechnology industry value: $ billion, 2016-21
Figure 2: United Kingdom biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: United Kingdom biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: United Kingdom biotechnology industry value forecast: $ billion, 2021-26
Figure 5: Forces driving competition in the biotechnology industry in the United Kingdom, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in the United Kingdom, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in the United Kingdom, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United Kingdom, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United Kingdom, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United Kingdom, 2021